View in EDS

Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024).

Saved in:

Bibliographic Details
Title:	Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003-2024).
Authors:	Rodrigues MA; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., de Pádua CAM; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., de Miranda Drummond PL; Fundação Ezequiel Dias - FUNED, Brazil, Belo Horizonte, Brazil., de Souza PHC; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., Malta JS; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil., Reis AMM; College of Pharmacy, Universidade Federal de Minas Gerais - UFMG, Brazil, 6627 Antonio Carlos Ave, Belo Horizonte, Minas Gerais, 31270010, Brazil. amreis@outlook.com.
Source:	Clinical drug investigation [Clin Drug Investig] 2026 Jun; Vol. 46 (6), pp. 641-653. Date of Electronic Publication: 2026 Apr 21.
Publication Type:	Journal Article
Journal Info:	Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1179-1918
DOI:	10.1007/s40261-026-01552-0